These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15257683)

  • 21. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
    Ashtari F; Bahar M; Aghaei M; Zahed A
    J Clin Neurosci; 2013 May; 20(5):676-8. PubMed ID: 23528410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-23 plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
    Shajarian M; Alsahebfosoul F; Etemadifar M; Sedaghat N; Shahbazi M; Firouzabadi FP; Dezashibi HM
    Immunol Invest; 2015; 44(1):36-44. PubMed ID: 25083738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS.
    van der Voort LF; Vennegoor A; Visser A; Knol DL; Uitdehaag BM; Barkhof F; Oudejans CB; Polman CH; Killestein J
    Neurology; 2010 Oct; 75(14):1228-33. PubMed ID: 20921509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon inhibitory activity in patients with multiple sclerosis.
    Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
    Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-interferon therapy increases serum beta2-microglobulin levels in hemodialysis patients.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Navarro MD; Aljama P
    Clin Nephrol; 2001 Nov; 56(5):378-81. PubMed ID: 11758008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofilament light as a prognostic marker in multiple sclerosis.
    Salzer J; Svenningsson A; Sundström P
    Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
    Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
    J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2 microglobulin as a surrogate marker for HIV infection: good correlation with CD4 counts.
    Wanchu A; Arora S; Bhatnagar A; Sud A; Bambery P; Singh S
    Indian J Pathol Microbiol; 2004 Apr; 47(2):298-301. PubMed ID: 16295507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
    Sormani MP; Stubinski B; Cornelisse P; Rocak S; Li D; De Stefano N
    Mult Scler; 2011 May; 17(5):541-9. PubMed ID: 21148262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
    Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
    Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal serum beta2-microglobulin as a marker for fetal infectious diseases.
    Dreux S; Rousseau T; Gerber S; Col JY; Dommergues M; Muller F
    Prenat Diagn; 2006 May; 26(5):471-4. PubMed ID: 16652403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Gruszka E
    Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
    Enzinger C; Fuchs S; Pichler A; Wallner-Blazek M; Khalil M; Langkammer C; Ropele S; Fazekas F
    Mult Scler; 2011 Jun; 17(6):695-701. PubMed ID: 21228028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.